Large pharmaceutical companies face significant challenges when moving high-value assets that have stringent storage temperature requirements, and BioLife’s new domestic transport service enables operational flexibility and reduced risk through the same provider SciSafe customers already trust with their sample management, the company added.
“Our ability to move client biomaterials safely at ultra-low temperatures is highly valued by pharmaceutical, and cell and gene therapy companies,” said Mike Rice, chairman and CEO of BioLife. “This service also highly complements our internal use of our portfolio of cold chain products, including the evo DV10 Smart Shipper, Stirling Ultracold freezers, and cryogenic liquid nitrogen storage freezers.
“These controlled-temperature trailers expand the volume, as well as the type of materials that can be moved and, in turn, increase the value we can offer our customers.”